Neogen | NEOG - Current Liabilities


Neogen reported $147.05M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Neogen USD 147.05M 850K Sep/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Pacific Biosciences Of California USD 63.21M 3.45M Sep/2025
Quidel USD 966.1M 198.2M Dec/2025
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 61.64M 2.41M Sep/2025
Surmodics USD 20.54M 347K Sep/2024
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Utah Medical Products USD 3.01M 757K Sep/2025
Zoetis USD 2.24B 428M Dec/2025